達安基因(002030.SZ):廣州生物工程中心擬參與轉融通證券出借業務
格隆匯6月15日丨達安基因(002030.SZ)公佈,公司於近日收到持股5%以上股東廣州生物工程中心有限公司《關於開展轉融通證券出借業務的函》(廣金生物函〔2021〕2號)。函件主要內容為:
“為有效盤活證券資產,提高國有資產收益率,生物中心擬參與轉融通證券出借業務,將持有的不超過14,034,400股達安基因股份(不超過達安基因總股本的1%)出借給中國證券金融股份有限公司,出借期限不超過182天,出借股份的所有權不會因開展該業務而發生轉移。”
截至公吿披露日,生物中心共持有公司股份210,516,909股,佔公司總股本的15.00%。
截至目前,生物中心尚未向中國證券金融股份有限公司出借公司股份,生物中心將於本公吿披露之日起15個交易日後再開展該業務。生物中心將根據市場情況、公司股價情況等決定是否參與及如何參與轉融通證券出借業務,本次轉融通證券出借業務計劃是否實施及實施的時間存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.